Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Biomaterials. 2009 Apr 23;30(22):3771–3779. doi: 10.1016/j.biomaterials.2009.03.044

Fig. 8.

Fig. 8

Effects of nebulized SCC10–LTP NPs on lung and spleen bacterial burden and likelihood of dissemination in a mouse model of Pseudomonas pneumonia. (A) Total number of bacteria recovered from the lungs of mice surviving at 72 h. Bar represents the mean bacterial count and was significantly different between samples (*p < 0.03). (B) Bacteremia as indicated by recovery of bacteria from the spleen after the indicated treatment in surviving mice analyzed at 72 h. Bar represents the mean bacterial count. (C) Bacteremia in all of the mice plotted as number of spleens in each treatment group with (black bars) or without (yellow bars) bacteria. Mice receiving SCC10–LTP NPs had a significantly reduced likelihood of bacteremia (*p < 0.03). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)